Charles G Drake Selected Research

transglutaminase 4

1/2021

TGM4: an immunogenic prostate-restricted antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles G Drake Research Topics

Disease

133	Neoplasms (Cancer) 01/2022 - 02/2002
91	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2005
19	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 07/2010
16	Melanoma (Melanoma, Malignant) 01/2021 - 07/2010
13	Inflammation (Inflammations) 12/2020 - 08/2006
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 08/2014
11	Neoplasm Metastasis (Metastasis) 12/2020 - 11/2013
9	Glioma (Gliomas) 10/2018 - 06/2013
8	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2014
6	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
5	Adenocarcinoma 11/2020 - 05/2009
5	Disease Progression 01/2017 - 10/2009
4	Human Influenza (Influenza) 01/2020 - 07/2007
4	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 07/2010
3	Lymphopenia (Lymphocytopenia) 01/2018 - 01/2014
3	Brain Neoplasms (Brain Tumor) 03/2016 - 06/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2014 - 07/2010
3	Virus Diseases (Viral Diseases) 09/2013 - 08/2006
2	Bites and Stings (Sting) 01/2022 - 01/2018
2	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2017
2	COVID-19 01/2020 - 01/2020
2	Hypoxia (Hypoxemia) 01/2020 - 02/2018
2	Atrophy 01/2019 - 04/2007
2	Experimental Melanoma 01/2019 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2009
2	Glioblastoma (Glioblastoma Multiforme) 12/2018 - 01/2017
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2018 - 12/2017

Drug/Important Bio-Agent (IBA)

34	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2011
26	AntigensIBA 01/2022 - 03/2005
21	sipuleucel-T (APC8015)FDA Link 01/2022 - 05/2010
16	VaccinesIBA 01/2021 - 05/2010
16	CytokinesIBA 01/2021 - 03/2013
16	AndrogensIBA 01/2021 - 03/2005
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
15	IpilimumabIBA 01/2021 - 08/2011
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
10	Monoclonal AntibodiesIBA 12/2018 - 02/2010
9	NivolumabIBA 01/2022 - 01/2013
9	Hormones (Hormone)IBA 01/2022 - 10/2007
9	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2012
9	Interleukin-8 (Interleukin 8)IBA 01/2021 - 06/2009
9	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2009
8	Pharmaceutical PreparationsIBA 01/2021 - 11/2012
8	LigandsIBA 01/2021 - 06/2012
8	Docetaxel (Taxotere)FDA Link 12/2020 - 10/2007
7	enzalutamideIBA 01/2022 - 02/2013
6	prostatic acid phosphataseIBA 01/2021 - 05/2010
6	Cancer VaccinesIBA 01/2020 - 01/2006
6	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2006
6	Messenger RNA (mRNA)IBA 01/2019 - 11/2012
6	Interleukin-10 (Interleukin 10)IBA 06/2017 - 06/2009
5	Interleukin-2 (IL2)IBA 01/2021 - 09/2015
5	pembrolizumabIBA 10/2020 - 04/2016
5	B7-H1 AntigenIBA 10/2020 - 01/2018
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 05/2012
5	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 07/2007
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 05/2009
4	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 10/2006
4	Programmed Cell Death 1 ReceptorIBA 02/2018 - 07/2007
4	PROSTVACIBA 01/2017 - 08/2011
3	InterferonsIBA 01/2022 - 06/2013
3	abirateroneIBA 01/2022 - 01/2018
3	ChemokinesIBA 01/2021 - 11/2016
3	A-Form DNA (A-DNA)IBA 11/2020 - 05/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2009
3	Blocking AntibodiesIBA 01/2018 - 01/2014
3	Finasteride (Propecia)FDA LinkGeneric 10/2017 - 03/2016
3	Interleukin-12 (IL 12)IBA 06/2017 - 09/2015
3	Interleukin-4 (Interleukin 4)IBA 06/2017 - 09/2015
3	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 06/2015
2	CarcinogensIBA 01/2022 - 04/2007
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2021
2	atezolizumabIBA 01/2022 - 01/2017
2	Granzymes (Granzyme)IBA 01/2021 - 10/2018
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 01/2019
2	AntibodiesIBA 01/2021 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2016
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 08/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 05/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 06/2013
2	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2020 - 01/2018
2	Biological ProductsIBA 01/2018 - 12/2014
2	Androgen Antagonists (Antiandrogens)IBA 01/2018 - 11/2014
2	CTLA-4 AntigenIBA 01/2017 - 01/2014
2	Hematoxylin (Haematoxylon)IBA 03/2016 - 05/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2016 - 05/2014

Therapy/Procedure

80	Immunotherapy 01/2022 - 02/2002
64	Therapeutics 01/2022 - 10/2004
35	Castration 01/2022 - 05/2010
16	Radiotherapy 01/2022 - 09/2008
10	Drug Therapy (Chemotherapy) 01/2017 - 07/2008
3	Cystectomy 08/2020 - 01/2016
3	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 09/2014
3	Aftercare (After-Treatment) 01/2020 - 02/2013
3	Cryosurgery 01/2020 - 08/2009
2	Nephrectomy 11/2020 - 01/2020
2	Cryotherapy (Therapy, Cold) 01/2020 - 08/2009
2	Immunomodulation 01/2020 - 01/2016
2	Neoadjuvant Therapy 04/2016 - 01/2016